Oppenheimer raised its price target on CME Group Inc. (NASDAQ:CME) to $300 from $282, maintaining an Outperform rating, as ...

Oppenheimer lifts CME Group stock price target on strong quarter ...

Oppenheimer raised the firm’s price target on CME Group to $245 from $228 and keeps an Outperform rating on the shares. The firm notes CME has benefited from the uncertainty on the pace of rate ...

The latest price target for CME Group (NASDAQ:CME) was reported by Oppenheimer on June 4, 2025. The analyst firm set a price target for $300.00 expecting CME to rise to within 12 months (a ...

The firm's analysts think highly of Target's long-term prospects, despite cutting their price target for the fifth time since last March.

CME Group (NASDAQ:CME – Free Report) had its price target hoisted by Oppenheimer from $245.00 to $258.00 in a research note released on Thursday morning, Benzinga reports. The firm currently has ...

Mayolo Lopez Guiterrez / Bloomberg via Getty Images Investment bank Oppenheimer cut its target price on Walmart to $95 per share, the lowest target tracked by Visible Alpha. The retailer could ...

Oppenheimer raised the firm’s price target on CME Group (CME) to $258 from $245 and keeps an Outperform rating on the shares. The firm says CME set another record quarter, with Q3 adjusted EPS ...

On Thursday, Oppenheimer maintained its Outperform rating on CME Group (NASDAQ: CME) shares and increased the price target to $258 from the previous $245. This adjustment follows CME Group's ...